223 related articles for article (PubMed ID: 16488311)
1. Butorphanol for treatment of intractable pruritus.
Dawn AG; Yosipovitch G
J Am Acad Dermatol; 2006 Mar; 54(3):527-31. PubMed ID: 16488311
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of epidural morphine induced pruritus with butorphanol].
Yokoyama Y; Yokoyama T; Nagao Y; Nakagawa T; Magaribuchi T
Masui; 2009 Feb; 58(2):178-82. PubMed ID: 19227171
[TBL] [Abstract][Full Text] [Related]
3. Treatment of pruritus with topically applied opiate receptor antagonist.
Bigliardi PL; Stammer H; Jost G; Rufli T; Büchner S; Bigliardi-Qi M
J Am Acad Dermatol; 2007 Jun; 56(6):979-88. PubMed ID: 17320241
[TBL] [Abstract][Full Text] [Related]
4. Transnasal butorphanol for the treatment of opioid-induced pruritus unresponsive to antihistamines.
Dunteman E; Karanikolas M; Filos KS
J Pain Symptom Manage; 1996 Oct; 12(4):255-60. PubMed ID: 8898510
[TBL] [Abstract][Full Text] [Related]
5. Use of Butorphanol as Treatment for Cholestatic Itch.
Golpanian RS; Yosipovitch G; Levy C
Dig Dis Sci; 2021 May; 66(5):1693-1699. PubMed ID: 32556969
[TBL] [Abstract][Full Text] [Related]
6. Systemic kappa opioid receptor agonists in the treatment of chronic pruritus: a literature review.
Phan NQ; Lotts T; Antal A; Bernhard JD; Ständer S
Acta Derm Venereol; 2012 Sep; 92(5):555-60. PubMed ID: 22504709
[TBL] [Abstract][Full Text] [Related]
7. The efficacy and safety of bile Acid binding agents, opioid antagonists, or rifampin in the treatment of cholestasis-associated pruritus.
Tandon P; Rowe BH; Vandermeer B; Bain VG
Am J Gastroenterol; 2007 Jul; 102(7):1528-36. PubMed ID: 17403073
[TBL] [Abstract][Full Text] [Related]
8. Effects of butorphanol on morphine-induced itch and analgesia in primates.
Lee H; Naughton NN; Woods JH; Ko MC
Anesthesiology; 2007 Sep; 107(3):478-85. PubMed ID: 17721251
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of naltrexone, an oral opiate receptor antagonist, in the treatment of pruritus in internal and dermatological diseases.
Metze D; Reimann S; Beissert S; Luger T
J Am Acad Dermatol; 1999 Oct; 41(4):533-9. PubMed ID: 10495371
[TBL] [Abstract][Full Text] [Related]
10. Open-label trial of oral nalmefene therapy for the pruritus of cholestasis.
Bergasa NV; Schmitt JM; Talbot TL; Alling DW; Swain MG; Turner ML; Jenkins JB; Jones EA
Hepatology; 1998 Mar; 27(3):679-84. PubMed ID: 9500694
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of oral naltrexone on pruritus in atopic eczema: a double-blind, placebo-controlled study.
Malekzad F; Arbabi M; Mohtasham N; Toosi P; Jaberian M; Mohajer M; Mohammadi MR; Roodsari MR; Nasiri S
J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):948-50. PubMed ID: 19453814
[TBL] [Abstract][Full Text] [Related]
12. Intravenous nalbuphine 50 microg x kg(-1) is ineffective for opioid-induced pruritus in pediatrics.
Nakatsuka N; Minogue SC; Lim J; Montgomery CJ; Court CA; Malherbe S; Csanyi-Fritz Y; Kearney RA; Phillips L; Reid K; Kingsley J; Ansermino JM
Can J Anaesth; 2006 Nov; 53(11):1103-10. PubMed ID: 17079637
[TBL] [Abstract][Full Text] [Related]
13. Mirtazapine for reducing nocturnal itch in patients with chronic pruritus: a pilot study.
Hundley JL; Yosipovitch G
J Am Acad Dermatol; 2004 Jun; 50(6):889-91. PubMed ID: 15153889
[TBL] [Abstract][Full Text] [Related]
14. Intranasal butorphanol rescue therapy for the treatment of intractable pruritus: A case series from the Johns Hopkins Itch Clinic.
Khanna R; Kwon CD; Patel SP; Belzberg M; Williams KA; Khanna R; Boozalis E; Kwatra SG
J Am Acad Dermatol; 2020 Nov; 83(5):1529-1533. PubMed ID: 32679280
[No Abstract] [Full Text] [Related]
15. Ondansetron and pruritus in chronic liver disease: a controlled study.
Jones EA; Molenaar HA; Oosting J
Hepatogastroenterology; 2007 Jun; 54(76):1196-9. PubMed ID: 17629069
[TBL] [Abstract][Full Text] [Related]
16. A randomized controlled trial of pentazocine versus ondansetron for the treatment of intrathecal morphine-induced pruritus in patients undergoing cesarean delivery.
Tamdee D; Charuluxananan S; Punjasawadwong Y; Tawichasri C; Patumanond J; Sriprajittichai P
Anesth Analg; 2009 Nov; 109(5):1606-11. PubMed ID: 19843798
[TBL] [Abstract][Full Text] [Related]
17. Naloxone for intractable pruritus?
Zuckerman E; Schar M; Korula J
Am J Gastroenterol; 1997 Jan; 92(1):183-4. PubMed ID: 8995978
[No Abstract] [Full Text] [Related]
18. Naltrexone for the management of post-burn pruritus: A preliminary report.
LaSalle L; Rachelska G; Nedelec B
Burns; 2008 Sep; 34(6):797-802. PubMed ID: 18325676
[TBL] [Abstract][Full Text] [Related]
19. Chronic pruritus: targets, mechanisms and future therapies.
Pogatzki-Zahn E; Marziniak M; Schneider G; Luger TA; Ständer S
Drug News Perspect; 2008 Dec; 21(10):541-51. PubMed ID: 19221635
[TBL] [Abstract][Full Text] [Related]
20. Sex differences in analgesia: a randomized trial of mu versus kappa opioid agonists.
Miller PL; Ernst AA
South Med J; 2004 Jan; 97(1):35-41. PubMed ID: 14746420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
